1 – 8 of 8
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
(
- Contribution to journal › Article
- 2013
-
Mark
Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries
(
- Contribution to journal › Article
- 2011
-
Mark
TGFβ-induced matrix production by bronchial fibroblasts in asthma: Budesonide and formoterol effects.
(
- Contribution to journal › Article
- 2010
-
Mark
Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD
(
- Contribution to journal › Article
- 2009
-
Mark
Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
(
- Contribution to journal › Article
- 2008
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
(
- Contribution to journal › Article
- 2006
-
Mark
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma
(
- Contribution to journal › Article